In addition, the overexpression of PRMT5 epigenetically reduces retinoblastoma proteins’ RB1 and RBL2 activity and increases the Polycomb-repressive complex 2 (PRC2) expression in NHL patient samples [75]. Here, PRMT5 is linked to non-Hodgkin lymphoma.